We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.6B
AUM Growth
+$69.6M
Cap. Flow
+$51.5M
Cap. Flow %
0.92%
Top 10 Hldgs %
21.06%
Holding
781
New
66
Increased
297
Reduced
239
Closed
62

Top Sells

Rank Stock Value
1
PII icon
Polaris
PII
+$36M
2
TROW icon
T. Rowe Price
TROW
+$31.5M
3
ELV icon
Elevance Health
ELV
+$27.8M
4
ITC
ITC HOLDINGS CORP
ITC
+$26.5M
5
AMAT icon
Applied Materials
AMAT
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 19.08%
2 Financials 18.2%
3 Consumer Discretionary 11.88%
4 Technology 11.08%
5 Industrials 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
476
Parker-Hannifin
PH
$127B
$286K 0.01%
+2,460
New +$297K
RRC icon
477
Range Resources
RRC
$9.73B
$285K 0.01%
5,780
+540
+10% +$30.8K
CLDX icon
478
Celldex Therapeutics
CLDX
$3.18B
$283K 0.01%
749
+237
+46% +$94.1K
TS icon
479
Tenaris
TS
$27.4B
$283K 0.01%
10,479
-357
-3% -$10.6K
HZNP
480
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$283K 0.01%
8,150
RLI icon
481
RLI Corp
RLI
$5.89B
$281K 0.01%
10,948
SCHX icon
482
Schwab US Large- Cap ETF
SCHX
$74.5B
$278K 0.01%
33,882
TGT icon
483
Target
TGT
$75.4B
$275K ﹤0.01%
3,368
+430
+15% +$34.8K
XLK icon
484
State Street Technology Select Sector SPDR ETF
XLK
$123B
$275K ﹤0.01%
13,304
+278
+2% +$5.93K
NUE icon
485
Nucor
NUE
$57.3B
$274K ﹤0.01%
+6,213
New +$298K
C icon
486
Citigroup
C
$223B
$267K ﹤0.01%
4,828
-475
-9% -$25.8K
ATR icon
487
AptarGroup
ATR
$8.45B
$265K ﹤0.01%
4,154
D icon
488
Dominion Energy
D
$58.5B
$263K ﹤0.01%
3,940
-250
-6% -$17.6K
PAYX icon
489
Paychex
PAYX
$45B
$263K ﹤0.01%
5,602
+144
+3% +$7.04K
DSGR icon
490
Distribution Solutions Group
DSGR
$1.61B
$260K ﹤0.01%
22,136
IJJ icon
491
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.88B
$259K ﹤0.01%
4,016
TDG icon
492
TransDigm Group
TDG
$65.6B
$259K ﹤0.01%
1,154
-30
-3% -$6.72K
OXLC
493
Oxford Lane Capital
OXLC
$944M
$258K ﹤0.01%
3,630
PSA.PRX
494
DELISTED
PUBLIC STORAGE DEPOSITARY REPSTG PFD SER X (MD)
PSA.PRX
$258K ﹤0.01%
11,000
-1,000
-8% -$23.5K
PSA.PRW
495
DELISTED
Public Storage Depositary Shares, Each Representing 1/1,000 of a 5.20% Cumulative Preferred Share of
PSA.PRW
$256K ﹤0.01%
11,000
-4,000
-27% -$95.9K
OLED icon
496
Universal Display
OLED
$3.9B
$255K ﹤0.01%
4,935
BBBY
497
DELISTED
Bed Bath & Beyond Inc
BBBY
$255K ﹤0.01%
3,700
+300
+9% +$21.5K
DISCK
498
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$254K ﹤0.01%
8,170
-410
-5% -$12.7K
XLB icon
499
State Street Materials Select Sector SPDR ETF
XLB
$8.82B
$251K ﹤0.01%
10,376
-7,942
-43% -$200K
SYT
500
DELISTED
Syngenta Ag
SYT
$251K ﹤0.01%
+3,070
New +$247K

Similar funds

Geneva Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Geneva Advisors held 781 positions worth $5.6B, up 1.3% from $5.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q2 2015 filing shows 66 new, 297 increased, 239 reduced and 62 closed positions. Its largest new stake was LinkedIn Corporation: 75,249 shares worth $15.5M. The largest sale was Polaris, an estimated $36M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Geneva Advisors's largest Q2 2015 buy was LinkedIn Corporation: 75,249 shares worth $15.5M.
  • Geneva Advisors added most to TD Ameritrade Holding Corp in Q2 2015, an estimated $41.7M increase.
  • Geneva Advisors's biggest Q2 2015 reduction was Polaris, cutting an estimated $36M.
  • Geneva Advisors fully exited Applied Materials in Q2 2015, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.6B portfolio in Q2 2015.
  • Geneva Advisors opened 66 new positions and closed 62 in Q2 2015.
  • Geneva Advisors's portfolio value rose 1.3% quarter-over-quarter to $5.6B.

Based on Geneva Advisors's 13F filing for Q2 2015, filed 3 Aug 2015.